JPRN-UMIN000004263已完成未知
A feasibility study of Pemetrexed/Bevacizumab in elderly patients with advanced non-small cell lung cancer (TORG1015) - TORG1015
Thoracic Oncology Research Group0 个研究点目标入组 12 人开始时间: 2010年9月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 70years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Patients with brain metastasis. 2. Patients with current or previous hemoptysis. 3. Patients treated with radiation therapy for thoracic region. 4. Patients with active severe infections. 5. Patients who have fever of over 38 degrees. 6. Patients with serious complication (cardiac affection, interstitial pneumonia, uncontrollable hypertension, or uncontrollable diabetes mellitus, etc.) 7. Patients with massive ascites, pleural or pericardial effusion. 8. Patients with concomitant malignancy. 9. Patients with history of drug allergies. 10. Patients with uncontrollable gastrointestinal ulceration. 11. Patients with current or previous (within one year) history of gastrointestinal perforation. 12. Patients treated with anticoagulation therapy. 13. Inappropriate patients for this study judged by the physicians.
研究者
相似试验
招募中
1 期
Feasibility study of pemetrexed / bevacizumab / erlotinib in chemotherapy naïve patients with non- small cell lung cancer harboring EGFR mutatioon-Small Cell Lung Cancer, Non-Squamous cell lung cancerJPRN-UMIN000014477ational Hospital Organization Kyushu Medical Center,Department of Respiratory Medicine12
招募中
2 期
Phase II study of Pemetrexed and Bevacizumab in Performance status 2 patients with advanced non-squamous non-small cell lung cancer.JPRN-UMIN000008124iigata Lung Cancer Treatment Group25
尚未招募
2 期
A phase II trial of pemetrexed/bevacizumab in the first-line treatment of elderly patients with advanced non-small cell lung cancer.elderly patients with stage IIIB/IV non-small cell lung cancer except for squamous cell carcinomaJPRN-UMIN000008764Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School36
已完成
2 期
Phase II study of Bevacizumab + Pemetrexed in elderly patients with advanced non-squamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000010733Central Japan Lung Study Group37
招募中
2 期
Phase II Study of Pemetrexed+Bevacizumab for previously untreated elderly patients with nonsquamous non-small-cell lung canceronsquamous non-small-cell lung cancerJPRN-UMIN000008781Toho university medical center sakura hospital25